Communiqués Cerus Corporation

Actions

CERS

US1570851014

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 27/06/2024			Varia. 5j.	Varia. 1 janv.
1,75 ^USD	+4,79%		+3,55%	-18,98%

02/05	Transcript : Cerus Corporation, Q1 2024 Earnings Call, May 02, 2024
02/05	Cerus Corporation réitère ses prévisions de résultats pour l'exercice se terminant le 31 décembre 2024	CI

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Cerus Corporation Announces Symposium and Abstracts at the 38th International Congress of the International Society of Blood Transfusion	24/06	AQ
Cerus Corporation Announces Symposium and Abstracts at the 38th International Congress of the International Society of Blood Transfusion	21/06	BU
Cerus Corporation Celebrates World Blood Donor Day 2024	14/06	BU
Cerus Corporation to Participate in 21st Annual Craig-Hallum Institutional Investor Conference	22/05	BU
Cerus: Q1 Earnings Snapshot	02/05	AQ
Cerus Corporation Announces First Quarter 2024 Financial Results	02/05	BU
The Nomination Committee's proposed Board composition	02/05	AQ
Cerus Corporation to Release First Quarter 2024 Financial Results on May 2, 2024	18/04	BU
Cerus Corporation Announces FDA Approval of Extended Shelf Life for INTERCEPT Platelet Processing Sets, Doubling Previous Shelf Life	27/03	AQ
Cerus Corporation Announces FDA Approval of Extended Shelf Life for INTERCEPT Platelet Processing Sets – Doubling Previous Shelf Life	26/03	BU
Cerus Corporation Announces Positive Topline Results for the Phase 3 Clinical Trial of the INTERCEPT Blood System for Red Blood Cells in Cardiovascular Surgery Patients	19/03	BU
Cerus: Q4 Earnings Snapshot	05/03	AQ
Cerus Corporation Announces Fourth Quarter and Full-Year 2023 Financial Results	05/03	BU
Microsize Announces Expanded CDMO Relationship with Cerus Corporation	27/02	AQ
Cerus Corporation to Release Fourth Quarter and Full-Year 2023 Financial Results on March 5, 2024	20/02	BU
Cerus Corporation to Participate in Upcoming Investor Conferences	01/02	BU
Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2023 Product Revenue and Provides Business Update	08/01	BU
Cerus Corporation to Participate in Upcoming Investor Conferences	03/11	BU
Cerus: Q3 Earnings Snapshot	02/11	AQ
Cerus Corporation Announces Third Quarter 2023 Financial Results	02/11	BU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Cerus Corporation

Actions

CERS

US1570851014

Communiqués

Filtres